Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Hechanova GroupEditha R Hechanova, Brenda P Rivera and Chrissie Ann L Barredo of Hechanova & Co look at frequently asked questions concerning the application and protection of designs in the Philippines -
Sponsored by Remfry & SagarShukadev Khuraijam of Remfry & Sagar describes how India is making steady and progressive steps in the right direction with a patent landscape that is undeniably positive
-
Sponsored by Remfry & SagarRemfry & SagarのShukadev Khuraijamが、間違いなく展望の開けた特許分野において、インドが正しい方向にいかに堅実に前進しているかを解説します。
-
Sponsored by Obhan & AssociatesObhan & Associates の Aparna KareerとSneha Agarwal が、データを要求するインド特許法の規定、データの性質そして提出段階について解説します。
-
Sponsored by Obhan & AssociatesAparna Kareer and Sneha Agarwal of Obhan & Associates discuss the provisions of Indian patent law under which experimental data is required, the nature of the data and submission stages
-
Sponsored by Wanhuida Intellectual PropertyHonghui Hu of Wanhuida Intellectual Property considers the impact of the structure-activity relationship on the inventiveness assessment of pharmaceutical compounds
